Camp4 Therapeutics Corp (CAMP)

Apr 10, 2025, 6:56 AM EDT - 15 days ago

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2

EWTX GNFT

Mar 27, 2025, 4:05 PM EDT - 4 weeks ago

CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 18, 2025, 8:00 AM EDT - 5 weeks ago

CAMP4 Appoints Multiple Industry Veterans to its Board of Directors

Mar 13, 2025, 10:39 PM EDT - 6 weeks ago

CORRECTION - CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025

Mar 13, 2025, 2:58 PM EDT - 6 weeks ago

CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025

Feb 6, 2025, 8:00 AM EST - 2 months ago

CAMP4 to Participate in Upcoming Investor Conferences

Jan 7, 2025, 4:05 PM EST - 3 months ago

CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones

Dec 2, 2024, 8:00 AM EST - 5 months ago

CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 21, 2024, 4:05 PM EST - 5 months ago

CAMP4 Reports Third Quarter 2024 Financial Results

Nov 5, 2024, 3:06 PM EST - 6 months ago

CAMP4 Analyst Highlights Rare Disease Platform Potential

Oct 10, 2024, 7:07 PM EDT - 7 months ago

CAMP4 Announces Pricing of Initial Public Offering

Oct 1, 2024, 4:30 PM EDT - 7 months ago

Camp4 Therapeutics Targets IPO On Early Positive Results

Sep 20, 2024, 3:35 PM EDT - 7 months ago

Genetic disease biotech CAMP4 Therapeutics files for a $75 million IPO

Sep 20, 2024, 2:23 PM EDT - 7 months ago

Kaiser Permanente-backed biopharma CAMP4 files for US IPO

Sep 20, 2024, 1:35 PM EDT - 7 months ago

CAMP4 Therapeutics IPO Registration Document (S-1)

Sep 17, 2024, 8:00 AM EDT - 7 months ago

CAMP4 Therapeutics Secures Orphan Drug Designation for CMP-CPS-001 for the Treatment of Urea Cycle Disorders